170 results
8-K
ATOS
Atossa Therapeutics Inc
12 Mar 24
Atossa Therapeutics Appoints Breast Cancer Specialist Tessa Cigler, M.D., M.P.H. to its Board of Directors
8:30am
will receive compensation as a non-employee director, as described in the Company’s Proxy Statement for its 2023 Annual Meeting of Stockholders filed
8-K
EX-99.1
tx66085de63 tq8
13 Nov 23
Atossa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
9:00am
8-K
7ltr0m9asqk3t
9 Nov 23
Departure of Directors or Certain Officers
9:00am
8-K
rnpa2 35zrk0isanm
6 Oct 23
Departure of Directors or Certain Officers
4:00pm
8-K
EX-3.2
i4r6iur
26 Apr 23
Amendments to Articles of Incorporation or Bylaws
4:10pm
8-K
EX-99.1
h60 9rktrp
8 Aug 22
Atossa Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update
4:00pm
8-K
EX-99.1
l1j0hlmniq7i69cn
9 May 22
Atossa Therapeutics Announces First Quarter 2022 Financial Results and Provides Corporate Update
4:00pm